Featured Research

from universities, journals, and other organizations

New drug target discovered for inflammatory bowel disease: Cytokine (IL-23)

Date:
March 31, 2011
Source:
Federation of American Societies for Experimental Biology
Summary:
A new discovery raises hope that new treatments for illnesses like Crohn's disease and ulcerative colitis are on the horizon. That's because they've identified IL-23, a cytokine used by the immune system to ward off disease, as a major contributor to the inflammation that is the hallmark of these illnesses.

A new discovery published in the April 2001 issue of Journal of Leukocyte Biology raises hope that new treatments for illnesses like Crohn's disease and ulcerative colitis are on the horizon. That's because they've identified IL-23, a cytokine used by the immune system to ward off disease, as a major contributor to the inflammation that is the hallmark of these illnesses.

Related Articles


With this information, it is now possible to develop new treatments that stop or reduce the damaging effects of IL-23, potentially bringing relief to millions of people with inflammatory bowel disease (IBD) and possibly other inflammatory illnesses as well.

"Our studies highlight the pathogenic role of IL-23 in the induction of mucosal injury in the gut," said Zhanju Liu, M.D., Ph.D., a researcher involved in the work from the Department of Gastroenterology at The Shanghai Tenth People's Hospital at Tongji University in Shanghai, China. "Moreover, our work also provides a novel approach in the management of IBD and some autoimmune diseases."

To make this discovery, Liu and colleagues analyzed IL-23 expression in intestinal mucosa using laboratory techniques that amplify and simultaneously quantify a specific DNA molecule, allowing for both detection and quantification of one or more specific sequences in a DNA sample. IL-23R expression was detected in a variety of cells from peripheral blood and intestinal mucosa of IBD patients, suggesting that IL-23 plays an important role in the induction of proinflammatory cytokine secretion as well as different types of immune cells including recently discovered Th17 helper T cells that are often important in inflammatory diseases.

"This research is important because it helps us better understand why people develop IBD, and defines one of the key pathways driving the excessive inflammation," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "Even more important, however, is that this study moves us a step closer to new treatments for these illnesses by targeting IL-23 and related proteins."


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Z. Liu, P. K. Yadav, X. Xu, J. Su, C. Chen, M. Tang, H. Lin, J. Yu, J. Qian, P.-C. Yang, X. Wang. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. Journal of Leukocyte Biology, 2011; DOI: 10.1189/jlb.0810456

Cite This Page:

Federation of American Societies for Experimental Biology. "New drug target discovered for inflammatory bowel disease: Cytokine (IL-23)." ScienceDaily. ScienceDaily, 31 March 2011. <www.sciencedaily.com/releases/2011/03/110331114844.htm>.
Federation of American Societies for Experimental Biology. (2011, March 31). New drug target discovered for inflammatory bowel disease: Cytokine (IL-23). ScienceDaily. Retrieved December 17, 2014 from www.sciencedaily.com/releases/2011/03/110331114844.htm
Federation of American Societies for Experimental Biology. "New drug target discovered for inflammatory bowel disease: Cytokine (IL-23)." ScienceDaily. www.sciencedaily.com/releases/2011/03/110331114844.htm (accessed December 17, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, December 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com
When You Lose Weight, This Is Where The Fat Goes

When You Lose Weight, This Is Where The Fat Goes

Newsy (Dec. 17, 2014) Can fat disappear into thin air? New research finds that during weight loss, over 80 percent of a person's fat molecules escape through the lungs. Video provided by Newsy
Powered by NewsLook.com
Why Your Boss Should Let You Sleep In

Why Your Boss Should Let You Sleep In

Newsy (Dec. 17, 2014) According to research out of the University of Pennsylvania, waking up for work is the biggest factor that causes Americans to lose sleep. Video provided by Newsy
Powered by NewsLook.com
Flu Outbreak Closing Schools in Ohio

Flu Outbreak Closing Schools in Ohio

AP (Dec. 17, 2014) A wave of flu illnesses has forced some Ohio schools to shut down over the past week. State officials confirmed one pediatric flu-related death, a 15-year-old girl in southern Ohio. (Dec. 17) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins